Daniel Fritz

Dan is the Industry Leader for the Innovative Medicines Initiative (IMI) PharmaLedger project, a public-private initiative of 29 companies and institutions focused on accelerating adoption of blockchain in healthcare. At Novartis, he is the Supply Chain Domain Architect at Novartis, responsible for IT standards and architecture direction as well as evaluation of emerging technologies. He has been at Novartis since 2002. He has 25 years of leadership and supply chain IT experience including the US Military, IT consulting, pharmaceutical manufacturing and global supply systems. He holds a B.S. from USMA and an MBA from Duke Fuqua and is APICS CPIM, CSCP, and SCOR-P certified.